Works about IMMUNE checkpoint inhibitors

Results: 5000

Successful multimodality treatment of anorectal melanoma after wide local excision: a case report.

Published in:

Frontiers in Oncology, 2025, p. 1, doi. 10.3389/fonc.2025.1535376

By:

Liang, Zhao;
Zongjian, Liu;
Chunlai, Pan;
Lihua, Wang;
Hexue, Yuan

Publication type:

Article

Predicting immune-related adverse events in patients with melanoma: the role of interleukin-7 rs16906115 polymorphism and lymphocyte dynamics.

Published in:

Frontiers in Immunology, 2025, p. 1, doi. 10.3389/fimmu.2025.1616325

By:

Açar, Fatma Pınar;
Acar, Caner;
Gunenc, Damla;
Arisoy, Çağlar;
Ece Solmaz, Asli;
Gecgel, Asli;
Yüksel, Haydar Çağatay;
Şahin, Gökhan;
Ozkan, Oguzcan;
Gokdere, Zeynep Sila;
Duman, Nilay;
Karaca, Burçak

Publication type:

Article

MACC1 is a potential prognostic biomarker for cancer immunotherapy in lung adenocarcinoma.

Published in:

Carcinogenesis, 2025, v. 46, n. 2, p. 1, doi. 10.1093/carcin/bgaf015

By:

Pan, Changqie;
Zhou, Zhiyuan;
Cao, Jun;
Zhang, Lemeng;
Cheng, Tianli;
Li, Haitao;
Jiang, Zhou;
Huang, Danhui;
Zeng, Dongqiang;
Luo, Yongzhong;
Wu, Jianhua

Publication type:

Article

Prognostic and Immunotherapeutic Role of TACC3 in Pancancer and Its Impact on Proliferation and Docetaxel Resistance in Lung Adenocarcinoma.

Published in:

Oncology, 2025, v. 103, n. 7, p. 628, doi. 10.1159/000542450

By:

Xu, Jianyu;
Zhu, Ying;
Liu, Qian;
Xu, Chenchang;
Wang, Wenjuan;
Sun, Jiantong;
Ding, Xinyuan;
Liu, Biao;
Chen, Lei

Publication type:

Article

The Potential of ESCO2 as a Prognostic and Immunotherapeutic Marker of Pan-Cancer and Its Role in Anti-PD-1 Treatment of Bladder Cancer.

Published in:

Oncology, 2025, v. 103, n. 7, p. 610, doi. 10.1159/000542188

By:

Guo, Wei;
Zhao, Shuo;
Yan, Keqiang;
Fan, Yidong;
Liu, Jikai

Publication type:

Article

GR.5 Identification of molecular biomarkers of response to combinatorial PARP inhibition and immune checkpoint blockade in IDH-Mutant Gliomas.

Published in:

2025

By:

Ellenbogen, Y;
Wang, K;
Patil, V;
Landry, A;
Liu, J;
Ajisebutu, A;
Yefet, L;
Gui, C;
Nassiri, F;
Chen, E;
Zadeh, G

Publication type:

Abstract

Tislelizumab-induced anaphylactic shock: a case report.

Published in:

Discover Oncology, 2025, v. 16, n. 1, p. 1, doi. 10.1007/s12672-025-03171-1

By:

Niu, Haiyu;
Song, Feixue;
Zhou, Xiaochun;
Lv, Qingfang;
Jin, Qiaoying;
Liu, Yating;
Yang, Luxi;
Luo, Benxin;
Wei, Hanwen

Publication type:

Article

Boosting cancer immunotherapy: drug delivery systems leveraging ferroptosis and immune checkpoint blockade.

Published in:

Frontiers in Immunology, 2025, p. 1, doi. 10.3389/fimmu.2025.1611299

By:

Zhang, Ting;
Gu, Fanlin;
Lin, Wei;
Shao, Haiyan;
Jiang, Aiguo;
Guan, Xingang

Publication type:

Article

Case Report: Immune checkpoint inhibitor-induced myositis without elevated creatine kinase.

Published in:

Frontiers in Immunology, 2025, p. 1, doi. 10.3389/fimmu.2025.1592385

By:

Begaj, Klajdi;
Wilhelm, Raphael;
Lepper, Alisa;
Kaufhold, Maike;
Veeser, Jakob;
Grabbe, Stephan;
Stege, Henner

Publication type:

Article

PD-L1 expression on tumor cells and tumor-infiltrating immune cells in thymic epithelial tumors detected with SP142 and SP263 antibodies.

Published in:

PLoS ONE, 2025, v. 19, n. 7, p. 1, doi. 10.1371/journal.pone.0327792

By:

Chubachi, Kei;
Tanaka, Hisashi;
Taima, Kageaki;
Tasaka, Sadatomo;
Kurose, Akira

Publication type:

Article

Cutaneous Side Effects of PD‐1 Inhibitors: A Single‐Center Retrospective Study.

Published in:

International Journal of Dermatology, 2025, v. 64, n. 6, p. 1066, doi. 10.1111/ijd.17683

By:

Pozsgai, Melánia;
Sebastian, Udoh Frieda‐Rex;
Oláh, Péter;
Németh, Viktória;
Gyulai, Rolland;
Lengyel, Zsuzsanna

Publication type:

Article

Efgartigimod therapy for immune checkpoint inhibitor–associated myasthenia gravis with myositis: a case report.

Published in:

BMC Neurology, 2025, v. 25, n. 1, p. 1, doi. 10.1186/s12883-025-04288-0

By:

Qi, Feiteng;
Sun, Qi;
Wang, Haifeng;
Zhang, Yong

Publication type:

Article

Post-translational modifications of cancer immune checkpoints: mechanisms and therapeutic strategies.

Published in:

Molecular Cancer, 2025, v. 24, n. 1, p. 1, doi. 10.1186/s12943-025-02397-5

By:

Jia, Haiqing;
Jiang, Lei;
Shen, Xiaoyu;
Ye, Huinan;
Li, Xinguang;
Zhang, Liwei;
Hu, Yanyan;
Song, Dandan;
Jia, Hui;
Wang, Zhe

Publication type:

Article

Abscopal Effects and Immunomodulation in Skin Cancer Therapy.

Published in:

American Journal of Clinical Dermatology, 2025, v. 26, n. 4, p. 555, doi. 10.1007/s40257-025-00943-x

By:

Nahm, William J.;
Sakunchotpanit, Goranit;
Nambudiri, Vinod E.

Publication type:

Article

Combination therapy with levofloxacin and the probiotic Clostridium butyricumMIYAIRI 588 enhances immune checkpoint inhibitor efficacy.

Published in:

International Journal of Cancer, 2025, v. 157, n. 5, p. 993, doi. 10.1002/ijc.35472

By:

Tajima, Kohei;
Hosonuma, Masahiro;
Funayama, Eiji;
Isobe, Junya;
Baba, Yuta;
Murayama, Masakazu;
Narikawa, Yoichiro;
Toyoda, Hitoshi;
Tsurui, Toshiaki;
Maruyama, Yuki;
Sasaki, Aya;
Amari, Yasunobu;
Yamazaki, Yoshitaka;
Nakashima, Rie;
Shida, Midori;
Sasaki, Akiko;
Sambe, Takehiko;
Wada, Satoshi;
Tsuji, Mayumi;
Kiuchi, Yuji

Publication type:

Article

ITM2A as a potential prognostic marker for triple-negative breast cancer.

Published in:

Journal of Cancer, 2025, v. 16, n. 9, p. 2903, doi. 10.7150/jca.114801

By:

Can Jiang;
Ruixin Feng;
Yongqian Zhao;
Jingting Zhang;
Na Han;
Yuzhu Zhang;
Guang Shu;
Gang Yin;
Maonan Wang

Publication type:

Article

LRP1B or TP53 mutations are associated with higher tumor mutational burden and worse survival in hepatocellular carcinoma.

Published in:

Journal of Cancer, 2021, v. 12, n. 1, p. 217, doi. 10.7150/jca.48983

By:

Longrong Wang;
Kai Yan;
Xigan He;
Hongxu Zhu;
Jia Song;
Shiqing Chen;
Shangli Cai;
Yiming Zhao;
Lu Wang

Publication type:

Article

YY1 enhances HIF-1α stability in tumor-associated macrophages to suppress anti-tumor immunity of prostate cancer in mice.

Published in:

Nature Communications, 2025, v. 16, n. 1, p. 1, doi. 10.1038/s41467-025-61560-0

By:

Li, Wenchao;
Chen, SaiSai;
Lu, Jian;
Mao, Weipu;
Zheng, Shiya;
Zhang, Minhao;
Wu, Tiange;
Chen, Yurui;
Lu, Kai;
Chu, Chunyan;
Shu, Chuanjun;
Hou, Yue;
Yang, Xue;
Shi, Naipeng;
Chen, Zhijun;
Zhang, Lihua;
Zhang, Lei;
Na, Rong;
Chen, Ming;
Ju, Shenghong

Publication type:

Article

Automated cell annotation and classification on histopathology for spatial biomarker discovery.

Published in:

Nature Communications, 2025, v. 16, n. 1, p. 1, doi. 10.1038/s41467-025-61349-1

By:

Li, Zhe;
Mirjahanmardi, Seyed Hossein;
Sali, Rasoul;
Eweje, Feyisope;
Gopaulchan, Matthew;
Kloker, Leon;
Zhang, Xiaoming;
Li, Guoxin;
Jiang, Yuming;
Li, Ruijiang

Publication type:

Article

Embracing cancer immunotherapy with manganese particles.

Published in:

Cellular Oncology (2211-3428), 2025, v. 48, n. 4, p. 899, doi. 10.1007/s13402-025-01070-9

By:

Moosavi Zenooz, Ali;
Eterafi, Majid;
Azarmi Giglou, Soheil;
Safarzadeh, Elham

Publication type:

Article

Oncolytic Adenovirus-Based Immunotherapy for Malignant Mesothelioma: Preclinical Advances and Future Perspectives.

Published in:

Advancements of Microbiology, 2025, v. 64, n. 2, p. 46, doi. 10.2478/am-2025-0004

By:

Garofalo, Mariangela;
Staniszewska, Monika;
Salmaso, Stefano;
Caliceti, Paolo;
Kuryk, Lukasz

Publication type:

Article

Rationale of using immune checkpoint inhibitors (ICIs) and anti-angiogenic agents in cancer treatment from a molecular perspective.

Published in:

Clinical & Experimental Medicine, 2025, v. 25, n. 1, p. 1, doi. 10.1007/s10238-025-01751-7

By:

Sherafat, Negar Sadat;
Keshavarz, Ali;
Mardi, Amirhossein;
Mohammadiara, Amirmohammad;
Aghaei, Mojtaba;
Aghebati-Maleki, Leili;
Mohammadi, Mohammad Hossein

Publication type:

Article

One step further in targeting acute leukemia by combining antibody-based immunotherapies and small molecule inhibitors.

Published in:

Cancer Cell International, 2025, v. 25, n. 1, p. 1, doi. 10.1186/s12935-025-03869-w

By:

Dozandeh-Jouybari, Armin;
Rohaninia, Erfan;
Faaliat, Sara;
Joudaki, Nazanin;
Ghandi, Sara;
Moghaddam, Maryam Talebi;
Taghiloo, Saeid;
Kazemi, Tohid

Publication type:

Article

The combination of chemotherapy and immune checkpoint inhibitors in recurrent extensive-stage small cell lung cancer: a case report.

Published in:

Journal of Cardiothoracic Surgery, 2025, v. 20, n. 1, p. 1, doi. 10.1186/s13019-025-03513-8

By:

Hu, Chunxiu;
Zhang, Mingtu;
Fang, Min;
Liu, Yi;
Yang, Zhengqi

Publication type:

Article

Taurine-mediated metabolic immune crosstalk indicates and promotes immunosuppression with anti-PD-1 resistance in bladder cancer.

Published in:

Frontiers in Immunology, 2025, p. 1, doi. 10.3389/fimmu.2025.1618439

By:

Liang, Zhengfang;
Nong, Fengwei;
Li, Zhenjie;
Chen, Runmin;
Zhao, Haoxu;
Huang, Yongping

Publication type:

Article

Benign tumors broaden the field of application for immunotherapy.

Published in:

Frontiers in Immunology, 2025, p. 1, doi. 10.3389/fimmu.2025.1593960

By:

Youssef, Mohamed A.;
Al-Sharif, Hisham;
McGrath, Brian T.;
Picken, Maria M.;
Le Poole, I. Caroline

Publication type:

Article

BRICS sequential therapeutic regimen as first-Line treatment for PD-L1-negative metastatic non-small cell lung cancer patients harboring EGFR/ALK wild-type status: a retrospective study.

Published in:

Frontiers in Immunology, 2025, p. 1, doi. 10.3389/fimmu.2025.1618110

By:

Chen, Jianxin;
Wang, Jian;
Fang, Weiqiang;
Wu, Yating;
Li, Hang;
Xu, Hui;
Zhu, Yunyun;
Cheng, Yanran;
Yu, Zongyang;
Peng, Yonghai

Publication type:

Article

Matching-adjusted indirect comparison of tislelizumab plus lenvatinib versus sintilimab plus bevacizumab biosimilar as first-line treatment for unresectable hepatocellular carcinoma.

Published in:

Frontiers in Immunology, 2025, p. 1, doi. 10.3389/fimmu.2025.1594935

By:

Wang, Kunyuan;
Liu, Chang;
Song, Xiaoling;
Zhao, Na;
Zheng, Xin

Publication type:

Article

The safety and effectiveness of sintilimab versus camrelizumab, both plus targeted drugs, in advanced hepatocellular carcinoma.

Published in:

Frontiers in Immunology, 2025, p. 1, doi. 10.3389/fimmu.2025.1585956

By:

Zhao, Chenglong;
Zhu, Qiongni;
Qian, Xiaoyan;
Fu, Zhonghua;
Zhang, Wei;
Wang, Yaqin

Publication type:

Article

Gut microbiome changes and cancer immunotherapy outcomes associated with dietary interventions: a systematic review of preclinical and clinical evidence.

Published in:

Journal of Translational Medicine, 2025, v. 23, n. 1, p. 1, doi. 10.1186/s12967-025-06586-0

By:

Somodi, Csenge;
Dora, David;
Horváth, Mátyás;
Szegvari, Gabor;
Lohinai, Zoltan

Publication type:

Article

Efficacy analysis of endostar combined with chemoradiotherapy and immune checkpoint inhibitors in locally advanced non-small cell lung cancer.

Published in:

Discover Oncology, 2025, v. 16, n. 1, p. 1, doi. 10.1007/s12672-025-03044-7

By:

Li, Bo;
Yang, Yaocheng;
Dong, Lina;
Zhuang, Dunmin;
Pan, Shixiang;
Lu, Haijun

Publication type:

Article

Advances in Adjuvant Therapy for Renal Cell Carcinoma: Perspectives on Risk Stratification and Treatment Outcomes.

Published in:

International Journal of Urology, 2025, v. 32, n. 7, p. 781, doi. 10.1111/iju.70050

By:

Furukawa, Junya;
Tomida, Ryotaro;
Daizumoto, Kei;
Sasaki, Yutaro;
Fukawa, Tomoya

Publication type:

Article

Case Report of Dermatomyositis With Features of the Wong Variant Developing Post‐Trastuzumab Therapy for Breast Cancer.

Published in:

Australasian Journal of Dermatology, 2025, v. 66, n. 3, p. 183, doi. 10.1111/ajd.14456

By:

LaMonica, Lauren C.;
Lang Houser, Margaret E.;
Harms, Paul W.;
Wang, Frank

Publication type:

Article

Fatal toxic epidermal necrolysis associated with an immune checkpoint inhibitor.

Published in:

Journal of Cutaneous Immunology & Allergy, 2025, p. 1, doi. 10.3389/jcia.2025.14584

By:

Seki, Chiaki;
Koike, Yuta;
Higuchi, Misato;
Ikenaga, Eri;
Waseda, Tomoka;
Ichiki, Mio;
Ehara, Daisuke;
Takenaka, Motoi;
Kusano, Keiko;
Sonoda, Yuuki;
Murota, Hiroyuki

Publication type:

Article

A mieloid eredetû szuppresszor sejtek szerepe a tumor mikrokörnyezetben, terápiás lehetôségek.

Published in:

Immunology Quarterly / Immunológiai Szemle, 2025, v. 17, n. 1, p. 36

By:

ADRIENN, GYÖNGYÖSI;
ÉVA, KORPOS;
JUDIT, KÁLLAI;
ÁRPÁD, LÁNYI

Publication type:

Article

The use of peripheral blood biomarkers for predicting the risk of immune-related adverse events in immune checkpoint inhibitor therapy.

Published in:

Annals of Clinical Biochemistry, 2025, v. 62, n. 4, p. 236, doi. 10.1177/00045632241312629

By:

Duvall, Louise E

Publication type:

Article

FDA approves durvalumab for perioperative immunotherapy for patients with muscle‐invasive bladder cancer: In a prespecified analysis, the trial demonstrated a statistically significant improvement in event‐free survival and overall survival.

Published in:

Cancer (0008543X), 2025, v. 131, n. 13, p. 1, doi. 10.1002/cncr.35912

By:

Nierengarten, Mary Beth

Publication type:

Article

Thyroid disorders as predictors of cemiplimab efficacy in recurrent/metastatic cervical cancer: real-world evidence from Poland.

Published in:

Frontiers in Immunology, 2025, p. 1, doi. 10.3389/fimmu.2025.1604826

By:

Pacholczak-Madej, Renata;
Lisik-Habib, Maja;
Mądry, Radosław;
Szarszewska, Monika;
Borysiewicz, Zuzanna;
Gabalewicz, Katarzyna;
Iwańska, Ewa;
Szatkowski, Wiktor;
Puskulluoglu, Mirosława;
Jakubowicz, Jerzy;
Blecharz, Paweł

Publication type:

Article

Tumor-suppressing multi-enterobacteria and PD-1/PD-L1 immune checkpoint inhibitor combination improves the outcome of hepatocellular carcinoma therapy.

Published in:

Frontiers in Immunology, 2025, p. 1, doi. 10.3389/fimmu.2025.1598436

By:

Wu, Dongjuan;
Fan, Yaohua;
Zhang, Mingsheng;
Wang, Xiaoguang;
He, Xuesong;
Guo, Xinwei;
Liu, Yangchen;
Cao, Chenxi;
Deng, Zhaoqun

Publication type:

Article

Case Report: Durable complete response of advanced-stage hepatocellular carcinoma to DEB−TACE combined with lenvatinib and camrelizumab.

Published in:

Frontiers in Immunology, 2025, p. 1, doi. 10.3389/fimmu.2025.1549675

By:

Xu, Baiguo;
Cui, Yufeng;
Wang, Ning;
Gao, Zhongsong;
Ye, Qing;
Xiang, Huiling

Publication type:

Article

Antibody treatment of hepatocellular carcinoma: a review of current and emerging approaches.

Published in:

Frontiers in Immunology, 2025, p. 1, doi. 10.3389/fimmu.2025.1533874

By:

El-Kafrawy, Sherif A.;
Elkafrawy, Mostafa S.;
Azhar, Esam I.;
Saeed, Anwaar;
Tabll, Ashraf A.

Publication type:

Article

A giant peritoneal mesothelioma extending to the pelvic floor: A case report and review of the literature.

Published in:

2025

By:

Thomas, Mathew;
Nandakumar, Harikrishnan;
Sampat, Parth;
Graziano, Stephen

Publication type:

Case Study

Extended field chemoradiation in M1a bladder carcinoma: A case report.

Published in:

Journal of Cancer Research & Therapeutics, 2025, v. 21, n. 3, p. 725, doi. 10.4103/jcrt.jcrt_2393_23

By:

Periasamy, Kannan;
Goyal, Shikha;
Kumar, Santosh;
Chandran, Vigneshwaran;
Kumar, Rajender

Publication type:

Article

Gamma Knife stereotactic radiotherapy combined with tislelizumab as later-line therapy in pMMR/MSS/MSI-L metastatic colorectal cancer: a phase II trial analysis.

Published in:

eLife, 2025, p. 1, doi. 10.7554/eLife.103559

By:

Yiran Zhang;
Hanyang Guan;
Shijin Liu;
Haoquan Li;
Zili Bian;
Jiashuai He;
Zhan Zhao;
Shenghui Qiu;
Tianmu Mo;
Xiangwei Zhang;
Zuyang Chen;
Hui Ding;
Xiaoxu Zhao;
Liang Wang;
Yunlong Pan;
Jinghua Pan

Publication type:

Article

TRPV1 inhibition sensitizes tumors to PD-1 blockade by reversing resistance to CTL-mediated killing.

Published in:

Scientific Reports, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41598-025-07120-4

By:

Son, Min Kyu;
Lee, Hyo-Jung;
Cho, Eunho;
Oh, Se Jin;
Kim, Tae Woo

Publication type:

Article

Abnormal gut microbiota may cause PD-1 inhibitor-related cardiotoxicity via suppressing regulatory T cells.

Published in:

Scientific Reports, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41598-025-05635-4

By:

Cao, Huili;
Dai, Huwei;
Li, Songshan;
Afzal, Zeeshan;
Wang, Xinyan;
Wen, Zeyu;
Xiao, Kaiyong;
Zhao, Yajing;
Li, Jin;
Yang, Bin

Publication type:

Article

Dual-energy CT iodine concentration as a biomarker for immunotherapy treatment response in metastatic melanoma and renal cell carcinoma patients.

Published in:

European Radiology, 2025, v. 35, n. 8, p. 4417, doi. 10.1007/s00330-025-11351-4

By:

Wiley, Natalie;
Zecevic, Mladen;
Ho, Vivian;
Stolzberg, Matthew J.;
Cox, Danielle;
Soloff, Erik V.;
Hall, Evan;
Wang, Carolyn L.

Publication type:

Article

IFITM3 enhances immunosensitivity via MHC-I regulation and is associated with the efficacy of anti-PD-1/-L1 therapy in SCLC.

Published in:

Molecular Cancer, 2025, v. 24, n. 1, p. 1, doi. 10.1186/s12943-025-02383-x

By:

Cui, Yanan;
Qiu, Tianyu;
Wang, Jiale;
Liu, Xinyu;
Luo, Libo;
Yin, Jizhong;
Zhi, Xinxin;
Wang, Wanying;
Feng, Gaohua;
Wu, Chunyan;
Zhao, Zhikai;
Zhang, Hua;
Li, Fei;
Wu, Fengying;
Ren, Shengxiang

Publication type:

Article

The Multifaceted Role of the IL‐2 Cytokine Family in Melanoma: Mechanisms, Therapeutic Implications, and Immune Modulation.

Published in:

Journal of Immunology Research, 2025, v. 2025, p. 1, doi. 10.1155/jimr/8890939

By:

Daghaighei, Mona;
Dodge, Samaneh;
Bolandi, Soheil;
Youssef, Boutros;
Attarde, Niket;
Maddahi, Moein;
Mostofi, Maryam;
Morovatshoar, Reza;
Mostafavi, Mehrnaz;
Majid, Dejbakht;
Joulani, Mohammadamin;
Tamimi, Pegah;
Sharafi, Malihe;
Behfar, Qumars;
Boushehri, Yasaman Ghodsi;
Azani, Alireza;
Goyal, Manish

Publication type:

Article

Single‑cell RNA sequencing reveals TMEM71 as an immunomodulatory biomarker predicting immune checkpoint blockade response in breast cancer.

Published in:

Discover Oncology, 2025, v. 16, n. 1, p. 1, doi. 10.1007/s12672-025-03068-z

By:

Li, Boyang;
Lin, Ruonan;
Hua, Yibo;
Ma, Binlin;
Chen, Yi

Publication type:

Article